CYTK
Cytokinetics Inc
61.40$
-2.2%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 75.8% | 76.2% | 79.0% | 70.1% | 70.9% | 79.0% | 75.6% | 72.3% | 68.0% | 64.4% | 65.9% | 62.8% | |
| 13.5% | 13.8% | 14.8% | 12.5% | 3.3% | 6.8% | 5.8% | 6.1% | 15.7% | 8.6% | 10.2% | 13.3% | |
| 72.8% | 74.6% | 76.6% | 69.4% | 70.4% | 76.8% | 74.2% | 70.0% | 67.0% | 61.9% | 64.3% | 60.6% | |
| 0.3% | 0.2% | 0.1% | 0.0% | 0.0% | 1.2% | 0.2% | 0.7% | 0.1% | 1.2% | 0.5% | 1.3% | |
| -0.3% | – | -0.1% | – | 0.0% | – | – | – | – | – | 0.0% | 0.0% | |
| 159.2% | 146.9% | 149.0% | 92.9% | 101.0% | 109.7% | 121.1% | 130.1% | 136.3% | 146.3% | 164.9% | 109.0% | |
| 10.5% | 12.5% | 11.0% | 6.7% | 7.6% | 12.8% | 12.6% | 10.7% | 9.9% | 14.2% | 15.6% | 9.4% | |
| 2.3% | 3.4% | 3.7% | 2.0% | 2.1% | 2.2% | 2.6% | 2.8% | 2.6% | 4.2% | 5.2% | 2.5% | |
| 1.9% | 2.6% | 1.6% | 0.6% | 0.8% | 1.5% | 1.1% | 1.3% | 1.5% | 1.6% | 1.9% | 1.1% | |
| 82.2% | 73.7% | 75.1% | 42.2% | 44.9% | 46.1% | 51.0% | 58.2% | 73.0% | 78.3% | 87.8% | 58.2% | |
| -59.2% | -46.9% | -49.0% | 7.1% | -1.0% | -9.7% | -21.1% | -30.1% | -36.3% | -46.3% | -64.9% | -9.0% | |
| -266.7% | -256.2% | -278.2% | -156.9% | -177.7% | -192.8% | -226.5% | -244.6% | -230.0% | -244.8% | -290.0% | -202.2% | |
| 13.0% | 12.0% | 12.6% | 7.2% | 8.2% | 8.4% | 9.4% | 9.7% | 8.4% | 8.6% | 9.7% | 6.9% |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.